CDK4 and benign prostatic hyperplasia: In the present study, it was found that the expression of PCNA, cyclin D1 and CDK4 was significantly increased in the BPH model group, which, however, could be significantly inhibited by QC treatment, as evidenced by RT-PCR and western blot analyses.